Grünenthal recruits AstraZeneca exec as CCO

German family-owned drugmaker Grünenthal has appointed Mark Fladrich to the position of chief commercial officer (CCO) responsible for the firm’s entire global commercial organization.

Currently Mr Fladrich is area vice president, Southern and Western Europe, at AstraZeneca (LSE: AZN), based in the UK. He will join Grünenthal effective September 1, 2017.

Mr Fladrich has almost 30 years of experience in the pharmaceutical industry, and more than 20 years at AstraZeneca. The 57 year old Australian by nationality brings a broad variety of expertise – from in-market knowledge to regional and global sales and marketing to Grünenthal. Key highlights include large country management roles in Germany as well as more recently in Australia and New Zealand with respectively over $1 billion of sales revenue in each country.